 |
|
|
| |
Tenofovir Disoproxil Fumurate (TDF) Demonstrates Good Efficacy and Safety in Asians with Chronic Hepatitis B (CHB) in Real-Life Settings
|
| |
| |
Reported by Jules Levin
Presented at 21st Conference of the Asian Pacific
Association for the Study of the Liver (APASL)
February 17-20, 2011
Bangkok, Thailand
S Chan1, C Pan2, H Bae3, A Yao4, H Trinh5, T Leduc6, C Hyun7, S Wang8, J Li9, X Ma10, S Tran11, L Mi12, M Li13, S Wu14, M Li15, J Li16, M Kim17, D Wu18, W Jing19, D Coombs20, A Snow-Lampert20, K Hirsch20, L Lou20, D Goodwin20, F Rousseau20, E Fagan20
1Private Offi ce of Sing Chan MD; 2Mount Sinai Services at Elmhurst Hospital, Mount Sinai School of Medicine, Flushing, NY; 3St. Vincent Medical Center, Los Angeles, CA; 4AE & LY Medical Associates, Flushing, NY; 5San Jose Gastroenterology, San Jose; 6Leduc Medical Group, Inc., Fountain Valley, CA; 7C.S.Hyun Clinic, Englewood, NJ; 8Charles B Wang Community Health Center New York, 9Maimonides Medical Center, Brooklyn, NY; 10Xiaoli Ma MD, Philadelphia, PA; 11Sang Tran, Falls Church, VA; 12New York Downtown Hospital, NewYork; 13Michael Li MD, Flushing, NY; 14Steven S.C. Wu MD, Hacienda Heights, CA; 15Mark Li MS, Silver Springs, MD; 16Palo Alto Medical Foundation, Mountain View, CA; 17FairfaxFamily Medical, Fairfax, VA; 18Northern CA Gastroenterology Consultants, Oakland, CA; 19Wuhua Jing MA PHD PC, New York, NY; 20Gilead Sciences, Foster City, CA, USA
|
| |
|
|
|
|
|
